Skip to main content
Premium Trial:

Request an Annual Quote

Elias Caro, Andrew Carr

Elias Caro, executive vice president of international diagnostics and global life sciences commercial operations at Beckman Coulter, has retired effective July 31, according to an 8-K filing with the US Securities and Exchange Commission. Caro will receive biweekly payments of $12,516.67 for a 17-month period that began Aug. 1, a prorated bonus for 2006 at target plus a lump sum payment of 10 percent of the bonus to reflect retirement plan contributions that would have been made had he continued to be employed, according to the filing.


Deltadot appointed Andrew Carr as chairman of its board this week.

Previously, Carr was a director of Amersham and CEO of Amersham Biosciences. He has been executive chairman and is now the non-executive chairman of Akubio.

He received his PhD in zoology from the
University of
Nottingham
.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.